Doxorubicin-Induced Oxidative Injury of Cardiomyocytes - Do We Have Right Strategies for Prevention?

doi 10.5772/34692

Full Text

Abstract

Available in

Date

Authors

Publisher

InTech

Related search

Spina Bifida: Do We Have the Right Policies?

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1985English

The Amelioration of Doxorubicin-Induced Oxidative Liver Injury by Ursodeoxycholic Acid

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Leadership and Management for Infection Prevention and Control: What Do We Have and What Do We Need?

Journal of Hospital Infection
MedicineInfectious DiseasesMicrobiology
2016English

Oxidative Damage to DNA: Do We Have a Reliable Biomarker?

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
1996English

Fit for Purpose: Do We Have the Right Tools to Sustain NTD Elimination?

BMC Proceedings
BiochemistryMedicineGeneticsMolecular Biology
2015English

Overexpression of Angiopoietin-1 Reduces Doxorubicin-Induced Apoptosis in Cardiomyocytes

Journal of Biomedical Research
BiochemistryMedicineGeneticsMolecular Biology
2012English

Estrogen Receptor Beta in Colorectal Cancer Prevention: Do We Have Conclusive Proof?

Journal of Genetic Syndromes & Gene Therapy
2013English

Wedelolactone-Loaded Micelles Ameliorate Doxorubicin-Induced Oxidative Injury in Podocytes by Improving Permeability and Bioavailability

Frontiers in Bioengineering and Biotechnology
BioengineeringBiomedical EngineeringHistologyBiotechnology
2019English

Differences in Doxorubicin-Induced Apoptotic Signaling in Adult and Immature Cardiomyocytes

Free Radical Biology and Medicine
BiochemistryPhysiology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy